SARS-CoV-2 Reinfection With Different SARS-CoV-2 Variants in Children, Ohio, United States

被引:5
|
作者
Wang, Huanyu [1 ,2 ]
Wright, Tori [1 ]
Everhart, Kathy [1 ]
Oyeniran, Sophonie J. [1 ,2 ]
Mejias, Asuncion [3 ,4 ,5 ]
Leber, Amy L. [1 ,2 ,3 ,4 ,6 ,7 ]
机构
[1] Nationwide Childrens Hosp, Dept Pathol & Lab Med, Columbus, OH USA
[2] Ohio State Univ, Dept Pathol, Columbus, OH USA
[3] Nationwide Childrens Hosp, Dept Pediat, Div Infect Dis, Columbus, OH USA
[4] Ohio State Univ, Columbus, OH USA
[5] Nationwide Childrens Hosp, Ctr Vaccines & Immun, Abigail Wexner Res Inst, Columbus, OH USA
[6] Nationwide Childrens Hosp, Coll Med & Publ Hlth, Clinical Microbiol & Immunoserol, 700 Childrens Dr, Columbus, OH 43205 USA
[7] Ohio State Univ, Pathol & Pediat, Coll Med & Publ Hlth, 700 Childrens Dr, Columbus, OH 43205 USA
关键词
COVID-19; pediatrics; reinfection; SARS-CoV-2;
D O I
10.1093/jpids/piad017
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Beginning in late 2021, we observed a significant increase in SARS-CoV-2 reinfections in pediatric patients evaluated at our institution. We aimed to characterize the children with SARS-CoV-2 reinfection, determine the number of SARS-CoV-2 reinfections, and characterize the intervals between two infections in our patient population. Methods From March 2020 to September 2022, we identified children <= 21 years old who had >= 2 SARS-CoV-2 infections using laboratory reports. We then defined the type of SARS-CoV-2 variant in the first and subsequent infections by mutation-specific typing or local epidemiology data. Clinical outcomes and the intervals between SARS-CoV-2 infections were assessed. Results We identified 541 children with >= 2 SARS-CoV-2 infections. The median interval between two infections was 229 days. The hospitalization rate was lower in the second infection. Reinfection counts were higher during the periods that Omicron variants predominated. Reinfection occurred more rapidly when Omicron variants were circulating with some occurring in less than 90 days. Conclusions As SARS-CoV-2 continues to evolve, there is a need for ongoing surveillance to identify the frequency and time interval between reinfections and to re-evaluate the definition of SARS-CoV-2 reinfections.
引用
收藏
页码:198 / 204
页数:7
相关论文
共 50 条
  • [1] Reinfection and reactivation of SARS-CoV-2
    Dowran, Razieh
    Damavandi, Amirmasoud Rayati
    Azad, Talat Mokhtari
    FUTURE VIROLOGY, 2022, : 835 - 844
  • [2] SARS-CoV-2 reinfection across a spectrum of immunological states
    McKittrick, Justine M.
    Burke, Thomas W.
    Petzold, Elizabeth
    Sempowski, Gregory D.
    Denny, Thomas N.
    Polage, Christopher R.
    Tsalik, Ephraim L.
    McClain, Micah T.
    HEALTH SCIENCE REPORTS, 2022, 5 (04)
  • [3] Reinfection With SARS-CoV-2: Implications for Vaccines
    Cohen, Jeffrey, I
    Burbelo, Peter D.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) : E4223 - E4228
  • [4] SARS-CoV-2 superinfection and reinfection with three different strains
    Perez-Lago, Laura
    Kestler, Martha
    Sola-Campoy, Pedro J.
    Rodriguez-Grande, Cristina
    Flores-Garcia, Ruben Francisco
    Buenestado-Serrano, Sergio
    Herranz, Marta
    Alcala, Luis
    Martinez-Laperche, Carolina
    Suarez-Gonzalez, Julia
    Catalan, Pilar
    Munoz, Patricia
    Garcia de Viedma, Dario
    TRANSBOUNDARY AND EMERGING DISEASES, 2022, 69 (05) : 3084 - 3089
  • [5] Epidemiological assessment of SARS-CoV-2 reinfection
    Almadhi, Marwa
    Alsayyad, Adel Salman
    Conroy, Ronan
    Atkin, Stephen
    Al Awadhi, Abdulla
    Al-Tawfiq, Jaffar A.
    AlQahtani, Manaf
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 123 : 9 - 16
  • [6] Characterization of SARS-CoV-2 isolated from a patient in Iran compared to SARS-CoV-2 different variants
    Ahmadi, Khadijeh
    Hosseinpour, Mahmood
    Rismani, Elham
    Hassaniazad, Mehdi
    Mafakher, Ladan
    Jahantigh, Hamid Reza
    Eftekhar, Ebrahim
    Gouklani, Hamed
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (04) : 1217 - 1232
  • [7] Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
    Chao, Chiao-Hsuan
    Cheng, Dayna
    Huang, Sheng-Wen
    Chuang, Yung-Chun
    Yeh, Trai-Ming
    Wang, Jen-Ren
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [8] SARS-CoV-2 reinfection and implications for vaccine development
    Nainu, Firzan
    Abidin, Rufika Shari
    Bahar, Muh Akbar
    Frediansyah, Andri
    Emran, Talha Bin
    Rabaan, Ali A.
    Dhama, Kuldeep
    Harapan, Harapan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (12) : 3061 - 3073
  • [9] A case with SARS-CoV-2 reinfection from India
    Munivenkatappa, Ashok
    Sahay, Rima R.
    Deshpande, Gururaj R.
    Patil, Deepak Y.
    Shete, Anita M.
    Sapkal, Gajanan N.
    Kumar, Ravish
    Narayana, Marappa
    Yadav, Pragya D.
    Shettar, Vijay
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2022, 40 (01) : 166 - 168
  • [10] Serological Markers of SARS-CoV-2 Reinfection
    Siddiqui, Sameed M.
    Bowman, Kathryn A.
    Zhu, Alex L.
    Fischinger, Stephanie
    Beger, Samuel
    Maron, Jenny S.
    Bartsch, Yannic C.
    Atyeo, Caroline
    Gorman, Matthew J.
    Yanis, Ahmad
    Hultquist, Judd F.
    Lorenzo-Redondo, Ramon
    Ozer, Egon A.
    Simons, Lacy M.
    Talj, Rana
    Rankin, Danielle A.
    Chapman, Lindsay
    Meade, Kyle
    Steinhart, Jordan
    Mullane, Sean
    Siebert, Suzanne
    Streeck, Hendrik
    Sabeti, Pardis
    Halasa, Natasha
    Musk, Elon R.
    Barouch, Dan H.
    Menon, Anil S.
    Nilles, Eric J.
    Lauffenburger, Douglas A.
    Alter, Galit
    MBIO, 2022, 13 (01):